Moderna Inc. said it has reached $18.4 billion worth of signed agreements for its Covid-19 vaccine in 2021, and Chief Medical Officer Tal Zaks will leave the company in late September.
The shot-maker is seeking a replacement for Zaks with “global and commercial experience” as it scales up manufacturing and shepherds other products to market over the next few years, according to a statement Thursday. Its Covid-19 vaccine sales have the potential to grow even further as the biotech continues to negotiate supply agreements with governments around the world.
Tal Zaks
Photographer: Rodrique Ngowi/AP Photo
“Moderna has been changed in a profound way,” Chief Executive ...
